Tag: Health Care

Displaying 121 - 140 of 912 results.

Pages

Akorn, Inc. has agreed to sell its rights to develop, manufacture, and market the generic injectable tuberculosis drug, rifampin, in order to settle FTC charges that Akorn’s proposed acquisition of VersaPharm Inc. and its parent company, VPI Holdings Corp., would likely be...
The settlement with TriVita, Inc. is part of the FTC’s ongoing efforts to stop over-hyped health claims.
Valeant Pharmaceuticals International, Inc. and Precision Dermatology, Inc. agreed to sell or relinquish rights to Precision’s branded single-agent topical tretinoins and generic Retin-A, common acne treatments, to settle FTC charges that Valeant’s proposed $475 million acquisition...
Cosmetics company L’Oréal USA, Inc. has agreed to settle Federal Trade Commission charges of deceptive advertising about its Lancôme Génifique and L’Oréal Paris Youth Code skincare products. According to the FTC’s complaint, L’Oréal made false and unsubstantiated claims that its Génifique and...
Pharmaceutical companies Actavis plc and Forest Laboratories, Inc. agreed to sell or relinquish their rights to four generic pharmaceuticals that treat hypertension, angina, cirrhosis, and prevent seizures to settle FTC charges that Actavis’s acquisition of Forest likely would be...
It is a time of unprecedented change in the way health care services are provided and paid for in this country. As with other sectors of our economy that have experienced dramatic change, industry participants are reacting by developing new models, learning from their experiences,...
FTC’s most recent fraud study shows that more consumers were victims of fraudulent weight-loss claims than of any other specific fraud type covered by the survey.
Supplement marketers i-Health, Inc. and Martek Biosciences Corporation have agreed to settle FTC charges of deceptive advertising for claiming that their BrainStrong Adult dietary supplement will improve adult memory and prevent cognitive decline.
The Federal Trade Commission has charged personal care company Lornamead, Inc. with deceiving consumers with exaggerated claims that its “Lice Shield” shampoo, stick, and spray products  will prevent or reduce the risk of getting head lice. Under an agreed-upon settlement, Lornamead will pay $500,...
The Federal Trade Commission has sued a Florida-based operation that capitalized on the green coffee diet fad by using bogus weight loss claims and fake news websites to market the dietary supplement Pure Green Coffee. Popularized on the syndicated talk show The Dr. Oz Show, green coffee bean...
Following a public comment period, the Federal Trade Commission has approved final consent orders settling charges that two marketers of genetically customized nutritional supplements deceptively advertised that their personalized nutritional supplements treat diabetes, heart disease, arthritis,...
Brief of the Federal Trade Commission as Amicus Curiae before the United States District Court for the Eastern District of Pennsylvania, addressing whether a branded company's commitment not to launch an authorized generic in competition with a generic company can constitute a...
Federal Trade Commission staff submitted written comments to Missouri State Representative Jeanne Kirkton in response to a request for comments on legislative proposals that would remove or change requirements for “collaborative practice arrangements” between Missouri physicians and Advanced...
Staff submitted a comment, in response to a request by Representative Jeanne Kirkton of the Missouri House of Representatives, regarding Missouri House Bills 1481 and 1491. HB 1491 would allow APRNs to assess and diagnose patients and order diagnostic and therapeutic tests and...

Pages